SBRT for Medically Inoperable Stage I Lung Cancer [360p]
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, describes the history and current use of stereotactic radiation therapy for inoperable lung lesions. Author: cancergrace Added: 01/29/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2019 Category: Cancer & Oncology Source Type: podcasts

SBRT for Oligometastatic Lung Cancer [720p]
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, defines oligometastatic lung cancer and describes the recent trend toward the use of stereotactic body radiation therap... Author: cancergrace Added: 01/29/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2019 Category: Cancer & Oncology Source Type: podcasts

Naiyer Rizvi, MD - The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care
The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care (Source: PeerView CME/CE Audio Podcast - Pulmonology)
Source: PeerView CME/CE Audio Podcast - Pulmonology - January 18, 2019 Category: Respiratory Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Top 5 Most Influential Trial Findings in Lung Cancer Management in 2018 (BMIC-073)
Dr. Jack West summarizes his list of the top 5 most influential trials in lung cancer that reported results in 2018, including why they matter. Author: BeaconMedIC Added: 12/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - December 22, 2018 Category: Cancer & Oncology Source Type: podcasts

What does the CheckMate-331 trial of nivolumab vs. chemo for relapsed SCLC tell us? (BMIC-072)
Dr. Jack West reviews the trial design, key results, and implications of the CheckMate-331 trial of nivolumab (Opdivo) vs. standard chemotherapy for relapsed small cell lung cancer. Author: BeaconMedIC Added: 12/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - December 20, 2018 Category: Cancer & Oncology Source Type: podcasts

Anjali Saqi, MD, MBA and Geoffrey R. Oxnard, MD - Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists
Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - December 7, 2018 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Edward B. Garon, MD, MS - Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice
Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - December 4, 2018 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

High vs. Standard Dose Chest Radiation in Stage III Lung Cancer [720p]
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, provides trial evidence showing that patients may not benefit from high dose chest radiation therapy vs. standard dose ... Author: cancergrace Added: 10/27/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 27, 2018 Category: Cancer & Oncology Source Type: podcasts

Neoadjuvant Chemotherapy vs. Chemo_Radiation for Stage IIIA NSCLC [720p]
Dr. Mark Socinski, University of Pittsburgh Medical Center, compares the use of chemotherapy to chemo/radiation in the preoperative setting in stage IIIA lung cancer. Author: cancergrace Added: 10/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 24, 2018 Category: Cancer & Oncology Source Type: podcasts

Defining Resectability in Stage IIIA Lung Cancer [720p]
Dr. Mark Socinski, University of Pittsburgh Medical Center, discusses the factors to consider in defining resectability in stage IIIa lung cancer. Author: cancergrace Added: 10/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Detecting Lung Cancer_ Presenting Symptoms [720p]
Dr. Gerard Silvestri, Medical University of South Carolina, describes some of the typical presenting symptoms of lung cancer. Author: cancergrace Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Potential Advantages, Disadvantages and Limitations of Lung Cancer Screening [720p]
GRACE - Global Resource for Advancing Cancer Education<br />Published on Feb 24, 2016<br />Dr. Gerard Silvestri, Medical University of South Carolina, discusses the benefits and drawbacks of lung cancer scree... Author: cancergrace Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts

How a Diagnosis of Lung Cancer is Made_ The Biopsy [720p](1)
GRACE - Global Resource for Advancing Cancer Education<br />Published on Feb 25, 2016<br />Dr. Gerard Silvestri, Medical University of South Carolina, describes several procedures used to obtain biopsy tissue... Author: cancergrace Added: 10/09/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 9, 2018 Category: Cancer & Oncology Source Type: podcasts

PET Scan Imaging_ What Does It Tell Us_ [720p]
Dr. Gerard Silvestri, Medical University of South Carolina, discusses the use of PET scans in lung cancer workup. Author: cancergrace Added: 10/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 8, 2018 Category: Cancer & Oncology Source Type: podcasts

& quot;Best Treatment First & quot;: Implications for front-Loading Combinations in Lung Cancer (BMIC-063)
Dr. Jack West describes an emerging theme that the best outcomes for patients with lung cancer and likely other cancer are best served by receiving the best agents up front, a strategy that implies a ... Author: BeaconMedIC Added: 09/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 6, 2018 Category: Cancer & Oncology Source Type: podcasts